Covidien, a provider of healthcare products, has launched EverFlex+ Self-Expanding Peripheral Stent System in Europe, to treat the superficial femoral artery (SFA) and proximal popliteal lesions.

The EverFlex+ Self-Expanding Peripheral Stent System is the next generation of EverFlex stent technology for the treatment of peripheral arterial disease.

The new EverFlex+ system is designed to reduce the risk of fracture when elongated, improving clinical outcomes for patients and offers more durability and flexibility for physicians.

Covidien Vascular Therapies president Joe Woody said EverFlex+ system further demonstrates their commitment to the advancement of stent technology and their goal to lead the industry in identifying and treating vascular diseases with breakthrough technologies.